Synopsis : Vaccine maker Bharat Biotech said that its nasal Covid-19 vaccine has been approved by the drug regulator for phase 3…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
COVID-19
-
-
CompaniesPfizer
Pfizer and BioNTech initiate study to evaluate Omicron-based COVID-19 vaccine in adults 18 to 55 years of age
by adminby adminSynopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the initiation of a clinical study to evaluate the safety,…
-
AgrochemicalsIndia
IIT Mandi researchers discover Phytochemicals in Himalayan plant that inhibit COVID-19 virus
by adminby adminSynopsis : Researchers show that phytochemical-rich petals of Rhododendron arboreum found in the Himalayan region, locally called “Buransh” show antiviral activity and…
-
Bharat BiotechCompanies
Bharat Biotech seeks full marketing approval from DCGI for Covaxin
by adminby adminSynopsis : Bharat Biotech has sought from the Drugs Controller General of India (DCGI) regular market approval for its COVID-19 vaccine Covaxin’,…
-
AgrochemicalsAstraZenecaGlobal Market
AstraZeneca sells another half-million doses of its COVID-19 antibody combo to the US
by adminby adminSummary : Order up. Shortly after topping off supplies of COVID-19 drugs from Pfizer and GlaxoSmithKline, the U.S. has asked for a…
-
AgrochemicalsCovid Drugs
EMA Receives application for Conditional Marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19
by adminby adminSynopsis: EMA has started evaluating an application for a conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 and ritonavir). The…
-
Covid DrugsGlobal Market
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001
by adminby adminSummary: -Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today confirms the previously communicated timelines of its clinical trials…
-
AgrochemicalsGlobal Market
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
by adminby adminHighlights: Screened approximately 700 subjects and expanding to Eastern Europe, including Turkey, as part of its clinical diversification plans to support global…
-
RegulatoryU.S FDA
Roche COVID-19 At-Home Test Granted FDA Emergency Use Authorization to expand access to Rapid Self-Testing Solutions in the United States
by adminby adminSummary : Rapid test to support the American public’s fight against the COVID-19 pandemic, with availability to purchase over-the-counter (OTC) at pharmacies…
-
Synopsis: The FDA’s authorization expands the drug’s use to fight Covid-19 to people under the age of 12 The therapy, Bamlanivimab plus…